High costs, specialised centres and eligibility requirements can limit availability. Patients should discuss approved options and potential risks with a sickle cell specialist.
Sickle cell gene therapies offer promise but access remains limited
Gene therapies are offering new treatment possibilities for sickle cell disease, but access remains a major challenge.